Suppression of experimental uveitis by a recombinant adeno-associated virus vector encoding interleukin-1 receptor antagonist
about
Ocular diseases: immunological and molecular mechanismsPharmacotherapy for uveitis: current management and emerging therapy.Emerging role of antioxidants in the protection of uveitis complications.Gene therapy for ocular diseasesRepublished review: Gene therapy for ocular diseases.Gene therapy with the caspase activation and recruitment domain reduces the ocular inflammatory responseNew options for uveitis treatment.
P2860
Q26747534-977EF412-1079-4C2A-95AF-6DE2197D465CQ34274075-14D8B9D8-D036-4B90-8B9B-52179B5C42F3Q34887046-DCD9A025-5AEE-4BAC-977B-38B9C2BEB150Q35160142-DCF719F4-69D2-4293-961A-A6D29A1340C8Q35210756-BDF88827-0685-4EB3-9A5A-8E3172DFB65FQ35594870-2D44FF25-635B-4997-A9AE-7BE4E6CA6FB0Q37256887-8660D2F5-279D-43C5-BB80-4618284B274A
P2860
Suppression of experimental uveitis by a recombinant adeno-associated virus vector encoding interleukin-1 receptor antagonist
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Suppression of experimental uv ...... erleukin-1 receptor antagonist
@en
Suppression of experimental uv ...... rleukin-1 receptor antagonist.
@nl
type
label
Suppression of experimental uv ...... erleukin-1 receptor antagonist
@en
Suppression of experimental uv ...... rleukin-1 receptor antagonist.
@nl
prefLabel
Suppression of experimental uv ...... erleukin-1 receptor antagonist
@en
Suppression of experimental uv ...... rleukin-1 receptor antagonist.
@nl
P2093
P2860
P921
P1433
P1476
Suppression of experimental uv ...... erleukin-1 receptor antagonist
@en
P2093
Chi-Ting Horng
Chih-Hung Wang
Ming-Ling Tsai
Show-Li Chen
Yeou-Ping Tsao
P2860
P304
P577
2009-08-08T00:00:00Z